LGC to showcase scientific excellence at 7th EBF open meeting and 1st EBF YSS

News (ZH) - LGC’s presentations will showcase scientific excellence through research and results covering the topics of supercharging reagents, development of robust cortisol assays, carryover in the immunoassay laboratory and ultrasensitivity immunoassays

LGC launches new service for stability testing

News (ZH) - This new service enables continuous recording and monitoring of essential data on the impact of environmental factors, such as temperature and humidity, on the quality of a pharmaceutical product

LGC launches cGMP cell-based assay capability

News (ZH) - The cGMP service is an extension to the existing cell-based assay capability that LGC’s experienced team offer for biopharmaceutical development

LGC and CCCMHPIE sign partnership agreement

News (ZH) - Under the agreement, LGC will bring its international expertise in the pharmaceutical market and in high product quality to CCCMHPIE member companies

LGC launches new Health Sciences business

News (ZH) - LGC and HFL combine to offer first in-house testing facility for both banned substances and additives testing

LGC and reinnervate collaborate to improve in vitro toxicity testing for drug discovery

News (ZH) - LGC Standards launches reinnervate’s 3D cell culture scaffold, alvetex®

FDA guidance on impurities in generic drugs drives LGC Standards’ expansion of product range

News (ZH) - New pharmaceutical reference substances and impurities catalogue from LGC Standards helps drug firms meet FDA guidelines

LGC Standards puts more drug discovery tools in your belt

News (ZH) - A new Tools for ADME/Tox resource guide is now available

OliX Pharmaceuticals signs agreement with LGC to accelerate production of asymmetric siRNA for the treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration

News (ZH) - LGC will produce active pharmaceutical ingredients for preclinical and clinical study of OLX301D programme

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

News (ZH) - DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK